KLIKNAD+ 500mg

KLIKNAD+ 500mg is based on research involving Nicotinamide Adenine Dinucleotide (NAD⁺), one of the most essential coenzymes found in living cells. Present in virtually every organism, NAD⁺ plays a central role in cellular energy production, mitochondrial function, DNA repair and intracellular signalling. Unlike hormones or receptor-targeting drugs, NAD⁺ functions as a metabolic cofactor, enabling hundreds of enzymatic reactions that sustain normal cellular physiology. It is particularly important for oxidative phosphorylation within mitochondria, where nutrients are converted into adenosine triphosphate (ATP), the primary energy currency of the cell. Interest in NAD⁺ biology has expanded considerably over the past two decades following discoveries linking declining NAD⁺ concentrations with ageing, metabolic dysfunction and impaired mitochondrial performance. Research has also identified important interactions between NAD⁺ and signalling proteins including sirtuins, PARPs (poly ADP-ribose polymerases) and CD38, which collectively regulate DNA repair, inflammation, stress adaptation and cellular resilience. Current research explores whether supporting NAD⁺ metabolism may influence healthy ageing, exercise physiology, neurodegeneration, cardiovascular health and metabolic disease. While laboratory evidence is substantial, many proposed clinical applications remain under active investigation.

NAD⁺ was first identified in the early twentieth century during investigations into cellular metabolism. It is now recognised as one of the most fundamental molecules in biology, participating in thousands of oxidation-reduction (redox) reactions every second. Within cells, NAD exists in two primary forms: • NAD⁺ (oxidised form) • NADH (reduced form) Together they form an electron transport system that enables efficient energy production. Every metabolically active tissue depends upon adequate NAD⁺ availability, including brain, skeletal muscle, heart, liver, kidneys and immune cells. Because of its central role in metabolism, NAD⁺ has become one of the most intensively studied molecules in ageing research.

CELLULAR ENERGY PRODUCTION The primary biological function of NAD⁺ is to transport electrons during metabolic reactions. During glycolysis and the citric acid (Krebs) cycle, nutrients are broken down, NAD⁺ accepts electrons, NADH carries these electrons to the mitochondrial electron transport chain, and ATP is generated through oxidative phosphorylation. Without adequate NAD⁺, efficient ATP production cannot occur. This relationship explains why NAD⁺ availability is closely linked to mitochondrial performance. MITOCHONDRIAL FUNCTION Mitochondria generate the majority of cellular ATP. Beyond energy production, they also regulate cellular signalling, oxidative stress, calcium homeostasis and programmed cell death (apoptosis). Experimental research suggests declining NAD⁺ concentrations may impair mitochondrial efficiency. Researchers continue investigating whether restoration of NAD⁺ pools influences mitochondrial respiration, ATP production, metabolic flexibility, cellular resilience and exercise adaptation. Many findings remain strongest in laboratory and animal models. SIRTUIN BIOLOGY One of the most significant discoveries in NAD⁺ research involved the identification of sirtuins, a family of NAD⁺-dependent enzymes. Humans possess seven known sirtuins (SIRT1–SIRT7). These proteins regulate numerous biological processes including DNA repair, mitochondrial biogenesis, inflammation, oxidative stress, circadian rhythm and metabolic adaptation. Because sirtuins require NAD⁺ to function, researchers have proposed that declining NAD⁺ availability during ageing may contribute to reduced cellular resilience. DNA REPAIR Cells continuously experience DNA damage resulting from ultraviolet radiation, oxidative stress, environmental exposures and normal metabolism. One of the primary DNA repair systems involves PARP enzymes, which consume NAD⁺ while repairing damaged DNA. During periods of extensive DNA damage, increased PARP activity may reduce intracellular NAD⁺ availability. Researchers continue studying how these competing metabolic demands influence ageing and disease progression.

AGEING RESEARCH Age-related declines in NAD⁺ concentrations have been reported across multiple tissues in laboratory studies. Potential contributing factors include increased CD38 activity, chronic inflammation, DNA damage, reduced biosynthesis and mitochondrial dysfunction. Experimental models suggest restoring NAD⁺ concentrations may improve several markers of cellular function. However, translating these observations into meaningful human clinical outcomes remains a major focus of ongoing research. EXERCISE PHYSIOLOGY Exercise increases energy demand and stimulates mitochondrial adaptation. Researchers have investigated how NAD⁺ metabolism interacts with AMPK activation, PGC-1α signalling, mitochondrial biogenesis, oxidative metabolism and recovery following exercise. Current evidence suggests NAD⁺ metabolism plays an important role in exercise adaptation, although supplementation studies in healthy individuals have produced mixed results. NEUROBIOLOGY The brain has exceptionally high metabolic requirements. Consequently, researchers have investigated NAD⁺ biology in relation to neurodegeneration, cognitive ageing, axonal maintenance, synaptic function and cellular stress resistance. Experimental studies suggest maintenance of NAD⁺ homeostasis may contribute to neuronal resilience. Human clinical evidence remains limited. CARDIOVASCULAR RESEARCH Cardiac muscle requires continuous ATP production throughout life. Research involving NAD⁺ has explored cardiac metabolism, vascular ageing, endothelial function, oxidative stress and ischaemia-reperfusion injury. Many observations originate from laboratory investigations rather than large human clinical trials. HUMAN CLINICAL EVIDENCE Human investigations continue to expand. Published studies have examined healthy ageing, metabolic syndrome, obesity, type 2 diabetes, cardiovascular biomarkers, exercise performance and neurodegenerative disease. Although many studies demonstrate increased circulating NAD⁺ metabolites following precursor supplementation, improvements in clinical outcomes remain variable. Researchers continue investigating which populations may benefit most from interventions targeting NAD⁺ metabolism.

NAD⁺ PRECURSORS Because NAD⁺ itself has limited oral bioavailability, much research has focused on compounds that serve as NAD⁺ precursors. These include: • Nicotinamide (NAM) • Nicotinic acid (Niacin) • Nicotinamide Riboside (NR) • Nicotinamide Mononucleotide (NMN) These molecules enter established biosynthetic pathways that regenerate intracellular NAD⁺. Current clinical research frequently investigates precursor supplementation rather than direct NAD⁺ administration. PHARMACOLOGICAL FOCUS Current pharmacological research focuses on cellular uptake, tissue distribution, NAD⁺ biosynthesis, precursor metabolism, intracellular compartmentalisation and route of administration. Understanding how NAD⁺ pools are regulated across different tissues remains one of the central challenges in this field.

SAFETY PROFILE NAD⁺ itself is an endogenous molecule required for normal physiology. Clinical investigations involving NAD⁺ precursors have generally demonstrated favourable short-term safety. Researchers continue evaluating long-term administration, dose optimisation, route-specific pharmacology, metabolic adaptation and population-specific responses. Long-term outcome studies remain ongoing. RESEARCH LIMITATIONS Several important limitations remain, including mixed clinical trial outcomes, differences between NAD⁺ and precursor supplementation, variable biomarkers, limited long-term human studies and ongoing uncertainty regarding optimal dosing strategies. While the biological importance of NAD⁺ is well established, many therapeutic applications remain investigational.

Current scientific priorities include: • Healthy ageing • Mitochondrial medicine • Neurodegenerative disease • Cardiometabolic health • Exercise adaptation • DNA repair • Precision metabolic medicine Rapid advances in mitochondrial biology continue to expand understanding of NAD⁺ as a central regulator of cellular physiology.